Ticker Details
Immunic, Inc.
IPO Date:	April 14, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$168.3M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 4.06%
Avg Daily Range (30 D):	$0.06 | 5.17%
Avg Daily Range (90 D):	$0.04 | 4.75%

Institutional Daily Volume
Avg Daily Volume:	.78M
Avg Daily Volume (30 D):	2.56M
Avg Daily Volume (90 D):	2.56M

Trade Size
Avg Trade Size (Sh.):	228
Avg Trade Size (Sh.) (30 D):	382
Avg Trade Size (Sh.) (90 D):	381

Institutional Trades
Total Institutional Trades:	85
Avg Institutional Trade:	$2.08M
Avg Institutional Trade (30 D):	$.7M
Avg Institutional Trade (90 D):	$.7M
Avg Institutional Trade Volume:	.35M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.64M
Avg Closing Trade (30 D):	$.51M
Avg Closing Trade (90 D):	$.51M
Avg Closing Volume:	345.3K

News

Dec 30, 2025 @ 3:51 PM Celiac Disease Market Report 2025-2035: Drivers, C... Source: Researchandmarkets.Com

Feb 29, 2024 @ 3:40 PM Immunic And 2 Other Stocks Under $2 Insiders Are B... Source: Avi Kapoor

Oct 10, 2023 @ 5:08 PM Why Startek Shares Are Trading Higher By 29%? Here... Source: Lisa Levin

Oct 10, 2023 @ 12:19 PM Why Immunic Shares Are Trading Higher By Around 13... Source: Lisa Levin

Apr 6, 2023 @ 6:10 PM Immunic's (IMUX) Ulcerative Colitis Study Shows Po... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.62	$-.07	$-.62
Diluted EPS	$-.62	$-.07	$-.62
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-97.17M	$-19.3M	$-97.17M
Operating Income / Loss	$-103.23M	$-23.33M	$-103.23M
Cost of Revenue
Net Cash Flow	$-20.19M	$-19.65M	$-20.19M
PE Ratio

Splits
Apr 15, 2019	1:40